A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer

Yutong Wang; Shanshan Wang; Yanmei Cui; Jie Zhang; Shuang Geng; Honglei Yin; Simiao Zhang; Qiufang Li; Yunliang Wang

doi:10.1016/j.gendis.2022.08.022

Genes & Diseases 2023, 10(2): 396-398 https://doi.org/10.1016/j.gendis.2022.08.022

Rapid Communication |

Open Access | Issue | Published: 11 October 2022

A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer

Show Author's Information Hide Author's Information Yutong Wang^{^a^,¹}, Shanshan Wang^{^c^,¹}, Yanmei Cui^{^e^,}, Jie Zhang^{^a}, Shuang Geng^{^c}, Honglei Yin^{^c}, Simiao Zhang^{^d}, Qiufang Li^{^b}, Yunliang Wang^{^d}(

)

School of Public Health and Laboratory of Qilu Medical University, Zibo, Shandong 255300, China

School of Nursing and Health of Zhengzhou University, Zhengzhou, Henan 450052, China

Department of Neurology, 960th Hospital of PLA, Zibo, Shandong 255300, China

Department of Neurology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450014, China

Shangqiu Medical College, Shangqiu, Henan 476100, China

¹ Co-first authors.

Peer review under responsibility of Chongqing Medical University.

Cite this article:

Wang Y, Wang S, Cui Y, et al. A focused transcriptomic analysis of the TP53-regulated genes identifies the GPI-anchored molecule-like protein (GML) as a favorable prognostic predictor of lung cancer. Genes & Diseases, 2023, 10(2): 396-398. https://doi.org/10.1016/j.gendis.2022.08.022